Literature DB >> 27741554

Characterization and in vivo performance of nitric oxide-releasing extracorporeal circuits in a feline model of thrombogenicity.

Marcus J Goudie1, Benjamin M Brainard2, Chad W Schmiedt2, Hitesh Handa1.   

Abstract

Infection and thrombosis are the two leading complications associated with blood contacting medical devices, and have led to the development of active materials that can delivery antibiotics or antithrombotic agents. Two key characteristics of these materials are the ability to produce controlled delivery, as well as minimal systemic delivery of the agent outside of the device site. Nitric oxide (NO) releasing materials are attractive as NO plays pivotal roles in the body's natural defense against bacterial infection, as well as regulation of platelet adhesion and activation. This work characterizes an NO-releasing extracorporeal circuit (ECC) under flow conditions for the first time, examining the effect of incubation and application of the top coating on leaching of NO donor and NO-release kinetics. Top coated ECCs with incubation delivered ca. 1% of the total NO potential over the 4-h period, whereas uncoated ECCs delivered over 4.5% of the total NO. Incubated ECC loops maintained a flux of 1.83 ± 0.50 × 10-10 mol min-1 cm-2 for the full 4 h duration. The NO-releasing ECC loops significantly increased the time-to-clot as compared to the corresponding control (11 ± 3.6 min control, 132 ± 93.0 min NO-releasing) when evaluated in vivo in a feline animal model.
© 2016 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 105A: 539-546, 2017. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  animal models; biomaterials; extracorporeal circuit; hemocompatibility; nitric oxide

Mesh:

Substances:

Year:  2016        PMID: 27741554     DOI: 10.1002/jbm.a.35932

Source DB:  PubMed          Journal:  J Biomed Mater Res A        ISSN: 1549-3296            Impact factor:   4.396


  7 in total

Review 1.  In Vitro models for thrombogenicity testing of blood-recirculating medical devices.

Authors:  Deepika N Sarode; Shuvo Roy
Journal:  Expert Rev Med Devices       Date:  2019-06-10       Impact factor: 3.166

2.  Biotemplated Synthesis and Characterization of Mesoporous Nitric Oxide-Releasing Diatomaceous Earth Silica Particles.

Authors:  Bryan M Grommersch; Jitendra Pant; Sean P Hopkins; Marcus J Goudie; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2018-01-11       Impact factor: 9.229

3.  Catalyzed Nitric Oxide Release Via Cu Nanoparticles Leads to an Increase in Antimicrobial Effects and Hemocompatibility for Short Term Extracorporeal Circulation.

Authors:  Megan E Douglass; Marcus J Goudie; Jitendra Pant; Priyadarshini Singha; Sean Hopkins; Ryan Devine; Chad W Schmiedt; Hitesh Handa
Journal:  ACS Appl Bio Mater       Date:  2019-05-07

4.  Nitric oxide releasing poly(vinylidene fluoride-co-hexafluoropropylene) films using a fluorinated nitric oxide donor to greatly decrease chemical leaching.

Authors:  Yang Zhou; Jinyi Tan; Jianfeng Wu; Qi Zhang; John Andre; Chuanwu Xi; Zhan Chen; Mark E Meyerhoff
Journal:  Acta Biomater       Date:  2019-04-10       Impact factor: 8.947

5.  A multi-defense strategy: Enhancing bactericidal activity of a medical grade polymer with a nitric oxide donor and surface-immobilized quaternary ammonium compound.

Authors:  Jitendra Pant; Jing Gao; Marcus J Goudie; Sean P Hopkins; Jason Locklin; Hitesh Handa
Journal:  Acta Biomater       Date:  2017-06-01       Impact factor: 8.947

6.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

7.  Liquid-infused nitric oxide-releasing (LINORel) silicone for decreased fouling, thrombosis, and infection of medical devices.

Authors:  Marcus J Goudie; Jitendra Pant; Hitesh Handa
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.